ProfileGDS4132 / 1562510_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 34% 37% 35% 33% 33% 29% 35% 26% 31% 32% 36% 38% 29% 49% 34% 39% 35% 33% 29% 33% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10185.2434
GSM201543Muscle PCOS pioglitazone 12187.20737
GSM201544Muscle PCOS pioglitazone 16189.812835
GSM201545Muscle PCOS pioglitazone 20190.115333
GSM201829Muscle PCOS pioglitazone 23189.152533
GSM201830Muscle PCOS pioglitazon 25174.253929
GSM201831Muscle PCOS pioglitazone 27188.421935
GSM201832Muscle PCOS pioglitazone 3164.2826
GSM201833Muscle PCOS pioglitazone 4173.40631
GSM201834Muscle PCOS pioglitazone 8176.622232
GSM201835Muscle PCOS after pioglitazone 10277.289136
GSM201836Muscle PCOS after pioglitazone 12286.316538
GSM201837Muscle PCOS after pioglitazone 16258.404529
GSM201838Muscle PCOS after pioglitazone 202121.0549
GSM201839Muscle PCOS after pioglitazone 23277.402634
GSM201840Muscle PCOS after pioglitazone 25294.991739
GSM201841Muscle PCOS after pioglitazone 27273.472535
GSM201842Muscle PCOS after pioglitazone 3265.206133
GSM201843Muscle PCOS after pioglitazone 4268.467429
GSM201844Muscle PCOS after pioglitazone 8277.927433